Cargando…
Acromicric Dysplasia Caused by a Novel Heterozygous Mutation of FBN1 and Effects of Growth Hormone Treatment
Autores principales: | Jin, Hyung Suk, Song, Ho young, Cho, Sung Yoon, Ki, Chang-Seok, Yang, Song Hyun, Kim, Ok-Hwa, Kim, Su Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107629/ https://www.ncbi.nlm.nih.gov/pubmed/27834076 http://dx.doi.org/10.3343/alm.2017.37.1.92 |
Ejemplares similares
-
A Review of Three Chinese Cases of Acromicric/Geleophysic Dysplasia with FBN1 Mutations
por: Shan, Yan-Chun, et al.
Publicado: (2021) -
Acromicric dysplasia with stiff skin syndrome‐like severe cutaneous presentation in an 8‐year‐old boy with a missense FBN1 mutation: Case report and literature review
por: Wang, Tao, et al.
Publicado: (2020) -
Acromicric dysplasia caused by a mutation of fibrillin 1 in a family: A case report
por: Shen, Ren, et al.
Publicado: (2023) -
Fibrillin-1 Mutations Causing Weill-Marchesani Syndrome and Acromicric and Geleophysic Dysplasias Disrupt Heparan Sulfate Interactions
por: Cain, Stuart A., et al.
Publicado: (2012) -
Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome
por: McInerney‐Leo, Aideen M., et al.
Publicado: (2020)